Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

A. Vennegoor; T. Rispens; B.W. van Oosten; M.P. Wattjes; M.J. Wondergem; C.E. Teunissen; D. van der Kleij; B.M.J. Uitdehaag; C.H. Polman; J. Killestein

doi:10.1177/1352458514541507

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

A. Vennegoor, T. Rispens, B.W. van Oosten, M.P. Wattjes, M.J. Wondergem, C.E. Teunissen, D. van der Kleij, B.M.J. Uitdehaag, C.H. Polman, J. Killestein

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	481-484
Journal	Multiple Sclerosis
Volume	21
Issue number	4
DOIs	https://doi.org/10.1177/1352458514541507
Publication status	Published - 2015

Access to Document

10.1177/1352458514541507

Cite this

Vennegoor, A., Rispens, T., van Oosten, B. W., Wattjes, M. P., Wondergem, M. J., Teunissen, C. E., van der Kleij, D., Uitdehaag, B. M. J., Polman, C. H., & Killestein, J. (2015). Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy. Multiple Sclerosis, 21(4), 481-484. https://doi.org/10.1177/1352458514541507

@article{bd7112e8811145a5805cb2a2f7899054,

title = "Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy",

author = "A. Vennegoor and T. Rispens and {van Oosten}, B.W. and M.P. Wattjes and M.J. Wondergem and C.E. Teunissen and {van der Kleij}, D. and B.M.J. Uitdehaag and C.H. Polman and J. Killestein",

year = "2015",

doi = "10.1177/1352458514541507",

language = "Undefined/Unknown",

volume = "21",

pages = "481--484",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "4",

}

Vennegoor, A, Rispens, T, van Oosten, BW, Wattjes, MP, Wondergem, MJ , Teunissen, CE, van der Kleij, D, Uitdehaag, BMJ , Polman, CH & Killestein, J 2015, 'Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy', Multiple Sclerosis, vol. 21, no. 4, pp. 481-484. https://doi.org/10.1177/1352458514541507

TY - JOUR

T1 - Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

AU - Vennegoor, A.

AU - Rispens, T.

AU - van Oosten, B.W.

AU - Wattjes, M.P.

AU - Wondergem, M.J.

AU - Teunissen, C.E.

AU - van der Kleij, D.

AU - Uitdehaag, B.M.J.

AU - Polman, C.H.

AU - Killestein, J.

PY - 2015

Y1 - 2015

U2 - 10.1177/1352458514541507

DO - 10.1177/1352458514541507

M3 - Article

C2 - 25078275

VL - 21

SP - 481

EP - 484

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 4

ER -